McKesson Specialty Health and US Oncology Network, The Woodlands, TX
Debra A. Patt , Bo He , Jody S. Garey , Paul Rowan , Michael D Swartz , Stephen Linder , Barry Don Brooks , Marcus A. Neubauer
Background: Cancer care is changing rapidly with more detailed understanding of disease and more numerous therapeutic choices. As treatment choice is more complex, mechanisms to improve compliance with evidence based treatment can improve the quality of cancer care. Methods: A retrospective cohort study was conducted from January 2014-May 2016 evaluating the impact of a clinical decision support system (CDSS) on compliance with evidence based pathways (EBP) across 9 statewide community based oncology practices. These EBP are developed with physician input on efficacy toxicity and value and incorporated in to a CDSS that is used within the Electronic Health Record (EHR) at point of care to alter the choice architecture a clinician sees when prescribing therapy. A multi-level logistic regression model was used to adjust for group effects on physician or practice behavior. SAS 9.4 software was used and GLIMMIX was applied. Individual physician benchmark compliance was evaluated using McNemar's test. Results: Regimen compliance with EBP was measured pre- and post- implementation of the CDSS tool across a large network encompassing 9 statewide practices and 633 physicians who prescribed over 30,000 individual patient treatment regimens over a 6 month period. The CDSS that is incorporated within the EHR significantly improved compliance with EBP across the entire cohort of practices, and in individual practices (see Table). Individual oncologists reached a target of 75% compliance more often (58% vs 72%) after implementation of the tool (p < 0.001). Conclusions: CDSS is a tool that improves compliance with EBP that is effective at improving targets of compliance broadly, at the practice, and at the individual clinician level. Clinical informatics solutions that influence physician behavior can be inclusive of physicians in design, iterative in process, and nudge as opposed to force clinician behavior to drive quality improvement. These clinical informatics solutions grow in importance as the complexity of cancer care continues to increase and we seek to improve upon the quality and value of care delivery.
Label | Odds Ratio of Regimen Compliance | 95% LCL | 95% UCL | Pr > |t| |
---|---|---|---|---|
Overall Post vs. Pre | 1.48 | 1.25 | 1.76 | 0.0007 |
Practice A | 1.60 | 1.33 | 1.94 | 0.0004 |
Practice B | 1.13 | 0.88 | 1.45 | 0.2930 |
Practice C | 1.39 | 1.08 | 1.79 | 0.0160 |
Practice D | 1.85 | 1.53 | 2.24 | < .0001 |
Practice E | 1.76 | 1.32 | 2.36 | 0.0021 |
Practice F | 1.71 | 1.38 | 2.11 | 0.0004 |
Practice G | 1.23 | 0.96 | 1.57 | 0.0897 |
Practice H | 1.37 | 1.12 | 1.67 | 0.0066 |
Practice I | 1.46 | 1.30 | 1.63 | < .0001 |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2024 ASCO Quality Care Symposium
First Author: M. Kelsey Kirkwood
2021 ASCO Quality Care Symposium
First Author: Ajeet Gajra
2022 ASCO Quality Care Symposium
First Author: Dinesh Kotak
2022 ASCO Quality Care Symposium
First Author: Vidya Kollu